Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Clinical trial NCT07254793 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07254793
Sponsor: University of Arizona
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoid Leukemia Acute Myeloid Leukemia Acute Undifferentiated Leukemia (AUL)Myelodysplastic Syndrome Chronic Myeloid Leukemia Non-Hodgkin Lymphoma

Start date: 2026-10-31
Primary completion: 2030-06-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.